Left ventricular dysfunction in COVID-19: A diagnostic issue
Résumé
No abstract available
Mots clés
Humans
Biomarkers
Drug Therapy
Combination
Diagnosis
Differential
Myocardial Infarction/diagnosis
*covid-19
Covid-19
SARS-CoV-2
*Pandemics
*Betacoronavirus/isolation & purification
*Myocarditis
*Type 2 myocardial infarction
Azithromycin/administration & dosage/adverse effects/therapeutic use
Coronavirus Infections/*complications/physiopathology
Cytokine Release Syndrome/etiology/physiopathology
Hydroxychloroquine/administration & dosage/adverse effects/therapeutic use
Hypoxia/etiology/physiopathology
Long QT Syndrome/chemically induced
Myocarditis/etiology/physiopathology
Pericarditis/etiology/physiopathology
Pneumonia
Viral/*complications/physiopathology
Systemic Inflammatory Response Syndrome/etiology/physiopathology
Tachycardia
Ventricular/etiology/physiopathology
Thrombophilia/blood/etiology
Ventricular Dysfunction
Left/*diagnosis/etiology/physiopathology
Ventricular Fibrillation/etiology/physiopathology